vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
27.35
-0.02 (-0.07%)
Dec 5, 2025, 4:00 PM EST - Market closed
vTv Therapeutics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for vTv Therapeutics stock ranges from a low of $35 to a high of $40. The average analyst price target of $37 forecasts a 35.28% increase in the stock price over the next year.
Price Target: $37.00 (+35.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for vTv Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +46.25% | Nov 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +31.63% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +31.63% | Apr 9, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +27.97% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +777.51% | Mar 7, 2023 |
Financial Forecast
Revenue This Year
n/a
from 1.02M
Revenue Next Year
n/a
EPS This Year
-4.12
from -3.20
EPS Next Year
-3.82
from -4.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.52 | -3.06 | ||||
| Avg | -4.12 | -3.82 | ||||
| Low | -4.83 | -4.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.